Xtant (XTNT) Director Jonn Beeson Receives DSU Award

What Happened
Jonn R. Beeson, a director of Xtant Medical Holdings, was granted 215,517 deferred stock units (DSUs) on August 15, 2026. The grant was recorded at $0.00 per unit (no cash exchanged). Each DSU represents a contingent right to receive one share of common stock; settlement of vested DSUs is deferred under the DSU award agreement.

Key Details

• Transaction date: 2026-08-15; Form 4 filed: 2026-08-18 (filing appears timely).
• Grant: 215,517 DSUs @ $0.00; reported value $0.
• Vesting/settlement: DSUs vest on August 15, 2027, conditioned on Beeson remaining a director; settlement of vested shares will occur later per the DSU agreement (deferred settlement).
• Footnote: The filing notes a total of 681,087 shares issuable upon settlement of DSUs granted under the 2023 Equity Incentive Plan, conditioned on continued service.
• Transaction type: Award/Grant (code A) — this is a compensation/retention award, not an open-market purchase or sale.

Context
DSU grants are commonly used to compensate and retain directors. Because these units vest only with continued service and settlement is deferred, they do not represent immediately tradable shares and should not be read as an immediate market buy or sell signal.